Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study

References

• Stattin P, Carlsson S, Holmstrom B, Vickers A, Hugosson J, Lilja H, et al. Prostate cancer mortality in areas with high and low prostate cancer incidence. J Natl Cancer Inst 2014;106:dju007.
   PubMedGoogle Scholar
• Nam RK, Cheung P, Herschorn S, Saskin R, Su J, Klotz LH, et al. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study. Lancet Oncol 2014;15:223–31.
   PubMed Web of Science ®Google Scholar
• Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 2013;368:436–45.
   PubMed Web of Science ®Google Scholar
• Hoffman RM, Koyama T, Fan KH, Albertsen PC, Barry MJ, Goodman M, et al. Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. J Natl Cancer Inst 2013;105:711–8.
   PubMedGoogle Scholar
• Hakkinen JT, Hakama M, Huhtala H, Shiri R, Auvinen A, Tammela TL, et al. Impact of LUTS using bother index in DAN-PSS-1 questionnaire. Eur Urol 2007;51:473–7; discussion 7-8.
   PubMed Web of Science ®Google Scholar
• Wallerstedt A, Tyritzis SI, Thorsteinsdottir T, Carlsson S, Stranne J, Gustafsson O, et al. Short-term results after robot-assisted laparoscopic radical prostatectomy compared to open radical prostatectomy. Eur Urol 2015;67:660–70.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• Van Hemelrijck M, Wigertz A, Sandin F, Garmo H, Hellstrom K, Fransson P, et al. Cohort profile: the National Prostate Cancer Register of Sweden and Prostate Cancer Data base Sweden 2.0. Int J Epidemiol 2013;42:956–67.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450
   PubMed Web of Science ®Google Scholar
• Berglund A, Garmo H, Tishelman C, Holmberg L, Stattin P, Lambe M. Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J Urol 2011;185:833–9.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
   PubMedGoogle Scholar
• Statistics Sweden. Longitudinal integration database for health insurance and labour market studies (LISA by Swedish acronym). http://www.scb.se. Available from: http://www.scb.se/Pages/List____257743.aspx (last accessed 23 June 2015).
   Google Scholar
• Hemelrijck MV, Garmo H, Wigertz A, Nilsson P, Stattin P. Cohort profile update: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base – a refined prostate cancer trajectory. Int J Epidemiol 2016;45:73–82.
   PubMed Web of Science ®Google Scholar
• Rothman JR, Greenland S, Lash TL. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins; 2008.
   Google Scholar
• Tomic K, Berglund A, Robinson D, Hjalm-Eriksson M, Carlsson S, Lambe M, et al. Capture rate and representativity of the National Prostate Cancer Register of Sweden. Acta Oncol 2015;54:158–63.
   PubMed Web of Science ®Google Scholar
• Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358:1250–61.
   PubMed Web of Science ®Google Scholar
• Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000;92:1582–92.
   PubMed Web of Science ®Google Scholar
• Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst 2009;101:888–92.
   PubMedGoogle Scholar
• Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2004;96:1358–67.
   PubMed Web of Science ®Google Scholar
• Resnick MJ, Penson DF. Functional outcomes after treatment for prostate cancer. N Engl J Med 2013;368:1654.
   PubMed Web of Science ®Google Scholar
• Plym A, Folkvaljon Y, Garmo H, Holmberg L, Johansson E, Fransson P, et al. Drug prescription for erectile dysfunction before and after diagnosis of localized prostate cancer. J Sex Med 2014;11:2100–8.
   PubMed Web of Science ®Google Scholar
• Chen AB, D'Amico AV, Neville BA, Earle CC. Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol 2006;24:5298–304.
   PubMed Web of Science ®Google Scholar
• Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. J Urol 2007;178:529–34; discussion 34.
   PubMed Web of Science ®Google Scholar
• Jarosek SL, Virnig BA, Chu H, Elliott SP. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Eur Urol 2015;67:273–80.
   PubMed Web of Science ®Google Scholar
• Kim S, Moore DF, Shih W, Lin Y, Li H, Shao YH, et al. Severe genitourinary toxicity following radiation therapy for prostate cancer – how long does it last? J Urol 2013;189:116–21.
   PubMed Web of Science ®Google Scholar
• Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 2005;23:2772–80.
   PubMed Web of Science ®Google Scholar
• Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol 2015;68:600–8.
   PubMed Web of Science ®Google Scholar
• Wallis CJ, Cheung P, Herschorn S, Saskin R, Su J, Klotz LH, et al. Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer. Br J Cancer 2015;112:977–82.
   PubMed Web of Science ®Google Scholar
• Loeb S, Roehl KA, Helfand BT, Catalona WJ. Complications of open radical retropubic prostatectomy in potential candidates for active monitoring. Urology 2008;72:887–91.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124–9.
   PubMed Web of Science ®Google Scholar